血清S100β蛋白水平与脑小血管病患者非痴呆型血管性认知障碍的相关性研究

doi:10.3969/j.issn.1673-5765.2018.11.007

摘要/Abstract

摘要：

目的探讨血清S100β蛋白水平与脑小血管病（cerebral small vessel disease，CSVD）患者非痴呆型血管性认知障碍（vascular cognitive impairment with no dementia，VCIND）的相关性。

方法收集2017年6月-2018年2月在潍坊医学院附属医院神经内科住院治疗的非痴呆CSVD患者60例，健康体检者30例，对所有研究对象进行蒙特利尔认知评估量表（Montreal cognitive assessment， MoCA）评定，将CSVD患者分为VCIND组30例和无认知障碍（no cognitive impairment，NCI）组30例。检测所有入组者血清S100β蛋白含量。用Pearson相关分析来分析血清S100β蛋白水平与VCIND的相关性， Logistic回归分析评价CSVD患者VCIND的可能危险因素。

结果 VCIND组血清S100β蛋白水平为（0.66±0.041）μg/L，高于NCI组（[ 0.62±0.040）μg/L]和对照组（[ 0.57±0.037）μg/L]（均P＜0.001）。Logistic回归分析结果显示，血清S100β蛋白水平是VCIND 的独立危险因素[比值比（odds ratio，OR）2.056，95%（confidence interval，CI）1.643～2.573，P＝0.003]。

结论 VCIND患者的血清S100β蛋白水平升高是VCIND的独立危险因素。

文章导读： 本研究通过对照分析发现脑小血管病患者血清S100β蛋白水平高于对照组，多因素分析显示血清S100β蛋白水平升高是脑小血管病患者轻度认知障碍的独立危险因素。

关键词: 血清S100β 蛋白；脑小血管病；非痴呆型血管性认知障碍

Abstract:

Objective To investigate the correlation between serum S100β protein level and vascular cognitive impairment with no dementia (VCIND) in patients with cerebral small vessel diseases (CSVD).

Methods Sixty CSVD inpatients (excluding dementia) in department of neurology and 30 healthy individuals from physical examination in the affiliated hospital of Weifang Medical College from June 2017 to February 2018 were enrolled in this study. All the subjects were assessed using Montreal cognitive assessment (MoCA), according to MoCA scores, the CSVD patients were divided into VCIND group (n =30) and no cognitive impairment (NCI) group (n =30), and the healthy subjects served as the control group. Serum S100β protein levels in all objects were measured by ELISA. The association between serum S100β protein level and VCIND in CSVD patients was analyzed by Pearson correlation analysis. Logistic regression analysis was applied to determine the independent risk factors of VCIND in patients with CSVD.

Results The serum S100β level in the VCIND group [(0.66±0.041) μg/L] were all higher than that in the NCI [(0.62±0.040) μg/L] and control groups [(0.57±0.037) μg/L] (all P <0.001). Logistic regression analysis showed that serum S100β level was an independent risk factor of VCIND [odds ratio (OR) 2.056, 95% confidence interval (CI) 1.643-2.573, P =0.003].

Conclusions Serum S100β level was an independent risk factor of VCIND.

Key words: Serum S100β protein; Cerebral small vessel disease; Vascular cognitive impairment with no dementia

高鸣, 陈娇, 赵倩倩, 蒲爽, 李雪梅. 血清S100β蛋白水平与脑小血管病患者非痴呆型血管性认知障碍的相关性研究[J]. 中国卒中杂志, 2018, 13(11): 1153-1157.

GAO Ming, CHEN Jiao, ZHAO Qian-Qian, PU Shuang, LI Xue-Mei. Correlation between Serum S100β Protein Level and Vascular Cognitive Impairment with No Dementia in Patients with Cerebral Small Vessel Diseases[J]. Chinese Journal of Stroke, 2018, 13(11): 1153-1157.

参考文献

[1] GORELICK P B，PANTONI L. Advances in

vascular cognitive impairment[J]. Stroke，2013，44

（2）：307-308.

[2] GONÇALVES C A，LEITE M C，Nardin P.

Biological and methodological features of the

measurement of S100B，a putative marker of brain

injury[J]. Clin Biochem，2008，41（10）：755-763.

[3] ROTHERMUNDT M，OHRMANN P，ABEL S，et

al. Glial cell activation in a subgroup of patients with

schizophrenia indicated by increased S100B serum

concentrations and elevated myoinositol[J]. Prog

Neuropsychopharmacol Biol Psychiatry，2007，31

（2）：361-364.

[4] CHAVES M L，CAMOZZATO A L，FERREIRA

E D，et al. Serum levels of S100B and NSE

proteins in Alzheimer's disease patients[J/OL].

J Neuroinflammation，2010，7：6. https：//doi.

org/10.1186/1742-2094-7-6.

[5] 脑小血管病诊治专家共识组. 脑小血管病的诊治专

家共识[J]. 中华内科杂志，2013，52（10）：893-896.

[6] WARDLAW J M，SMITH C，DICHGANS M.

Mechanisms of sporadic cerebral small vessel disease：

insights from neuroimaging[J]. Lancet Neurol，2013，

12（5）：483-497.

[7] MORAN C，PHAN T G，SRIKANTH V K.

Cerebral small vessel disease：a review of clinical，

radiological，and histopathological phenotypes[J].

Int J Stroke，2015，7（1）：36-46.

[8] 中华医学会神经病学分会. 中国脑小血管病诊治共

识[J]. 中华神经科杂志，2015，48（10）：838-844.

[9] INSEL T，CUTHBERT B，GARVEY M，et al.

Research domain criteria（RDoC）：toward a new

classification framework for research on mental

disorders[J]. Am J Psychiatry，2010，167（7）：748-

751.

[10] 《中国高血压基层管理指南》修订委员会. 中国高血

压基层管理指南（2014年修订版）[J]. 中华健康管理

学杂志，2015，30（1）：10-30.

[11] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南

（2013年版）[J]. 中华内分泌代谢杂志，2014，30（10）：

447-498.

[12] 中国成人血脂异常防治指南修订联合委员会. 中国

成人血脂异常防治指南解读（2016年修订版）[J]. 中

国循环杂志，2016，31（10）：937-939.

[13] 冠心病合理用药指南（第2版）[J]. 中国医学前沿杂

志，2018，10（6）：1-130.

[14] NASREDDINE Z S，PHILLIPS N A，BÉDIRIAN V，

et al. The Montreal Cognitive Assessment，MoCA：a

brief screening tool for mild cognitive impairment[J].

J Am Geriatr Soc，2010，53（4）：695-699.

[15] JUNG N Y，HAN C E，KIM H J，et al. Tract-

Specific Correlates of Neuropsychological Deficits

in Patients with Subcortical Vascular Cognitive

Impairment[J]. J Alzheimers Dis，2016，50（4）：

1125-1135.

[16] PANTONI L. Cerebral small vessel disease：from

pathogenesis and clinical characteristics to

therapeutic challenges[J]. Lancet Neurology，2010，9

（7）：689-701.

[17] WARDLAW J M，SMITH E E，BIESSELS G J，et

al. Neuroimaging standards for research into small

vessel disease and its contribution to ageing and

neurodegeneration[J]. Lancet Neurology，2013，12

（8）：822-838.

[18] 陈娟，李瑜霞，周晶，等. MoCA、MMSE与AVLT在

非痴呆型缺血性小血管性认知障碍的应用[J]. 华北

理工大学学报（医学版），2018，40（1）：25-30.

[19] 战珑，韩建阁，翟文倩，等. 不同麻醉方案对术后认

知功能及S100β蛋白的影响[J]. 中国中西医结合急救

杂志，2015，22（4）：398-401.

[20] CHEN L，CHEN L，LV Y，et al. Tetrandrine

ameliorates cognitive impairment via inhibiting

astrocyte-derived S100B activation in a rat model of

chronic cerebral hypoperfusion[J]. Neurol Res，2013，

35（6）：614-621.

[21] FEI W，ZOU Z R，DONG Y，et al. Correlation

between serum S100β protein levels and cognitive

dysfunction in patients with cerebral small vessel

disease：a case-control study[J/OL]. Biosci Rep，2017，

37（2）：BSR20160446. https：//doi.org/10.1042/

BSR20160446.

[22] GAO Q，FAN Y MU L Y，et al. S100B and ADMA

in cerebral small vessel disease and cognitive

dysfunction[J]. J Neurol Sci，2015，354（1-2）：27-32.

[23] 张兰青，郑华如，李大军，等. 缺血性脑卒中患者颈

动脉内膜中层厚度与血浆同型半胱氨酸的相关性[J].

中国老年学杂志，2014，34（6）：1661-1662.

[24] WANG T，SUN Z W，SHAO L Q，et al. Diagnostic

Values of Serum Levels of Homocysteine and

Uric Acid for Predicting Vascular Mild Cognitive

Impairment in Patients with Cerebral Small Vessel

Disease[J/OL]. Med Sci Monit，2017，23：2217-

2225. https：//www.ncbi.nlm.nih.gov/pmc/articles/

PMC5436427/.